BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CardioMag Imaging, Inc. (CMI) Receives Registration Certificate From People's Republic Of China State Food And Drug Administration


1/12/2006 11:05:04 AM

SCHENECTADY, N.Y., Jan. 12 /PRNewswire/ -- CardioMag has received official certification from the State Food and Drug Administration (SFDA) of the People's Republic of China, that its product -- a Magnetocardiograph (MCG) -- has been inspected by the SFDA and is permitted to be sold commercially in the Chinese medical market. The device, which non-invasively detects the magnetic field generated by a person's electric activity in the heart, is already installed at the TEDA International Cardiovascular Hospital located in Tianjin, China.

Carl H. Rosner, President and CEO stated: "We are very pleased with this vote of confidence by the Chinese Government Agency, because receipt of this certification will allow CardioMag to enter the very large Chinese hospital marketplace for both research and clinical patient applications. It is estimated that there are about 20,000 hospitals in all of China, of which up to 2,000 are potential customers."

He further noted that it appears, Chinese patients in particular like the fact that an MCG procedure takes less than ten minutes to perform, is risk-free, and does not require injections or exposes the patient to X-ray radiation. With the capability to generate a thousand field mapping images per heartbeat, CardioMag's MCG system provides unprecedented insight into the human heart at work.

Safe Harbor Statement: The statements presented in this press release which are not historical facts are forward looking statements which involve various important assumptions, risks, uncertainties and other factors set forth here, including but not limited to, market acceptance by healthcare providers, obtaining FDA approval for future claims, insurance reimbursement policies, and growth of the market.

CardioMag Imaging, Inc.

CONTACT: Carl H. Rosner, Executive Chairman of CardioMag Imaging, Inc.,+1-518-381-1000, ext. 63; or Eric Burns, +011-44-1943-833990, or LisaBaderoon, +011-44-207-4665000, both of Buchanan Communications - U.K., forCardioMag Imaging, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES